Presented by: Julia Carnevale, MD, Assistant Professor, University of California San Francisco Covered by: Hannah Abrams, MD “Solid tumors…
On March 29, 2023, the U.S. Food and Drug Administration approved pembrolizumab for adult and pediatric patients with unresectable or…